Skip to Content

18 Results Found

  • Article
  • Open Access
6 Citations
4,072 Views
16 Pages

Fluorescence-Based Binding Characterization of Small Molecule Ligands Targeting CUG RNA Repeats

  • Zhihua Chang,
  • Ya Ying Zheng,
  • Johnsi Mathivanan,
  • Vibhav A. Valsangkar and ,
  • Jinxi Du,
  • Reham A. I. Abou-Elkhair,
  • Abdalla E. A. Hassan and
  • Jia Sheng
  • + 3 authors+ 0 author

Pathogenic CUG and CCUG RNA repeats have been associated with myotonic dystrophy type 1 and 2 (DM1 and DM2), respectively. Identifying small molecules that can bind these RNA repeats is of great significance to develop potential therapeutics to treat...

(This article belongs to the Special Issue Biophysical Study of the Structure, Dynamics, and Function of Nucleic Acids 2.0)
  • Review
  • Open Access
10 Citations
8,598 Views
17 Pages

Deciphering the Complex Molecular Pathogenesis of Myotonic Dystrophy Type 1 through Omics Studies

  • Jorge Espinosa-Espinosa,
  • Anchel González-Barriga,
  • Arturo López-Castel and
  • Rubén Artero

27 January 2022

Omics studies are crucial to improve our understanding of myotonic dystrophy type 1 (DM1), the most common muscular dystrophy in adults. Employing tissue samples and cell lines derived from patients and animal models, omics approaches have revealed t...

(This article belongs to the Special Issue Myotonic Dystrophy: From Molecular Pathogenesis to Therapeutics 2.0)
  • Communication
  • Open Access
2 Citations
4,432 Views
8 Pages

Aurintricarboxylic Acid Decreases RNA Toxicity in a C. elegans Model of Repeat Expansions

  • Maya Braun,
  • Shachar Shoshani,
  • Anna Mellul-Shtern and
  • Yuval Tabach

20 December 2021

Pathologic expansions of DNA nucleotide tandem repeats may generate toxic RNA that triggers disease phenotypes. RNA toxicity is the hallmark of multiple expansion repeat disorders, including myotonic dystrophy type 1 (DM1). To date, there are no avai...

  • Article
  • Open Access
12 Citations
3,731 Views
20 Pages

Therapeutic Targeting of the GSK3β-CUGBP1 Pathway in Myotonic Dystrophy

  • Maggie Lutz,
  • Miranda Levanti,
  • Rebekah Karns,
  • Genevieve Gourdon and ,
  • Diana Lindquist,
  • Nikolai A. Timchenko and
  • Lubov Timchenko
  • + 2 authors+ 0 author

Myotonic Dystrophy type 1 (DM1) is a neuromuscular disease associated with toxic RNA containing expanded CUG repeats. The developing therapeutic approaches to DM1 target mutant RNA or correct early toxic events downstream of the mutant RNA. We have p...

(This article belongs to the Section Molecular Pathology, Diagnostics, and Therapeutics)
  • Review
  • Open Access
30 Citations
12,142 Views
25 Pages

Molecular Therapies for Myotonic Dystrophy Type 1: From Small Drugs to Gene Editing

  • Mariapaola Izzo,
  • Jonathan Battistini,
  • Claudia Provenzano,
  • Fabio Martelli and ,
  • Beatrice Cardinali and
  • Germana Falcone
  • + 1 author+ 0 author

Myotonic dystrophy type 1 (DM1) is the most common muscular dystrophy affecting many different body tissues, predominantly skeletal and cardiac muscles and the central nervous system. The expansion of CTG repeats in the DM1 protein-kinase (DMPK) gene...

(This article belongs to the Special Issue Rare Monogenic Diseases: Molecular Pathophysiology and Novel Therapies 2.0)
  • Review
  • Open Access
20 Citations
6,729 Views
18 Pages

Myotonic dystrophy type 1 (DM1) is a complex genetic disease affecting many tissues. DM1 is caused by an expansion of CTG repeats in the 3′-UTR of the DMPK gene. The mechanistic studies of DM1 suggested that DMPK mRNA, containing expanded CUG r...

(This article belongs to the Special Issue Myotonic Dystrophy: From Molecular Pathogenesis to Therapeutics)
  • Article
  • Open Access
238 Views
18 Pages

30 October 2026

Background/Objectives: Myotonic dystrophy type 1 (DM1) is the most common form of adult-onset muscular dystrophy. DM1 is caused by a CTG trinucleotide repeat expansion in the 3′-untranslated region of the DMPK gene. Expanded CUG repeat RNA form...

(This article belongs to the Section Human Genomics and Genetic Diseases)
  • Review
  • Open Access
25 Citations
5,874 Views
17 Pages

10 September 2022

Myotonic Dystrophies type 1 (DM1) and type 2 (DM2) are complex multisystem diseases without disease-based therapies. These disorders are caused by the expansions of unstable CTG (DM1) and CCTG (DM2) repeats outside of the coding regions of the diseas...

(This article belongs to the Special Issue Myotonic Dystrophy: From Molecular Pathogenesis to Therapeutics 2.0)
  • Review
  • Open Access
33 Citations
8,944 Views
17 Pages

CRISPR/Cas Applications in Myotonic Dystrophy: Expanding Opportunities

  • Renée H.L. Raaijmakers,
  • Lise Ripken,
  • C. Rosanne M. Ausems and
  • Derick G. Wansink

CRISPR/Cas technology holds promise for the development of therapies to treat inherited diseases. Myotonic dystrophy type 1 (DM1) is a severe neuromuscular disorder with a variable multisystemic character for which no cure is yet available. Here, we...

(This article belongs to the Special Issue Myotonic Dystrophy: From Molecular Pathogenesis to Therapeutics)
  • Article
  • Open Access
11 Citations
5,455 Views
24 Pages

Vorinostat Improves Myotonic Dystrophy Type 1 Splicing Abnormalities in DM1 Muscle Cell Lines and Skeletal Muscle from a DM1 Mouse Model

  • Nafisa Neault,
  • Aymeric Ravel-Chapuis,
  • Stephen D. Baird,
  • John A. Lunde and ,
  • Mathieu Poirier,
  • Emiliyan Staykov,
  • Julio Plaza-Diaz,
  • Gerardo Medina,
  • Francisco Abadía-Molina and
  • Alex E. MacKenzie
  • + 6 authors+ 1 author

14 February 2023

Myotonic dystrophy type 1 (DM1), the most common form of adult muscular dystrophy, is caused by an abnormal expansion of CTG repeats in the 3′ untranslated region of the dystrophia myotonica protein kinase (DMPK) gene. The expanded repeats of t...

(This article belongs to the Special Issue New Pharmacological Approaches for Rare Diseases)
  • Review
  • Open Access
94 Citations
14,528 Views
20 Pages

Short tandem repeat (STR) or microsatellite, expansions underlie more than 50 hereditary neurological, neuromuscular and other diseases, including myotonic dystrophy types 1 (DM1) and 2 (DM2). Current disease models for DM1 and DM2 propose a common p...

(This article belongs to the Special Issue Myotonic Dystrophy: From Molecular Pathogenesis to Therapeutics)
  • Article
  • Open Access
2 Citations
1,282 Views
17 Pages

Elevated Levels of Active GSK3β in the Blood of Patients with Myotonic Dystrophy Type 1 Correlate with Muscle Weakness

  • Katherine Jennings,
  • Cuixia Tian,
  • Rebeccah L. Brown,
  • Paul S. Horn and ,
  • Benedikt Schoser,
  • Hani Kushlaf,
  • Nikolai A. Timchenko and
  • Lubov Timchenko
  • + 3 authors+ 0 author

5 November 2025

Myotonic Dystrophy type 1 (DM1) is a complex disease affecting multiple tissues, including skeletal and cardiac muscles, the brain and the eyes. DM1 results from an expansion of CTG repeats in the 3′ UTR of the DMPK gene. Previously, we describ...

(This article belongs to the Special Issue 25th Anniversary of IJMS: Updates and Advances in Molecular Pathology, Diagnostics, and Therapeutics)
  • Review
  • Open Access
117 Citations
16,556 Views
27 Pages

An Overview of Alternative Splicing Defects Implicated in Myotonic Dystrophy Type I

  • Andrea López-Martínez,
  • Patricia Soblechero-Martín,
  • Laura de-la-Puente-Ovejero,
  • Gisela Nogales-Gadea and
  • Virginia Arechavala-Gomeza

22 September 2020

Myotonic dystrophy type I (DM1) is the most common form of adult muscular dystrophy, caused by expansion of a CTG triplet repeat in the 3′ untranslated region (3′UTR) of the myotonic dystrophy protein kinase (DMPK) gene. The pathological...

(This article belongs to the Special Issue Genetic Advances in Neuromuscular Disorders: From Gene Identification to Gene Therapy)
  • Article
  • Open Access
18 Citations
6,414 Views
22 Pages

Transcriptome Analysis Reveals Altered Inflammatory Pathway in an Inducible Glial Cell Model of Myotonic Dystrophy Type 1

  • Cuauhtli N. Azotla-Vilchis,
  • Daniel Sanchez-Celis,
  • Luis E. Agonizantes-Juárez,
  • Rocío Suárez-Sánchez and ,
  • J. Manuel Hernández-Hernández,
  • Jorge Peña,
  • Karla Vázquez-Santillán,
  • Norberto Leyva-García,
  • Arturo Ortega and
  • Oscar Hernández-Hernández
  • + 9 authors+ 4 authors

26 January 2021

Myotonic dystrophy type 1 (DM1), the most frequent inherited muscular dystrophy in adults, is caused by the CTG repeat expansion in the 3′UTR of the DMPK gene. Mutant DMPK RNA accumulates in nuclear foci altering diverse cellular functions incl...

(This article belongs to the Special Issue Molecular Basis of Neuromuscular Diseases)
  • Review
  • Open Access
7 Citations
4,070 Views
18 Pages

Regulatory Potential of Competing Endogenous RNAs in Myotonic Dystrophies

  • Edyta Koscianska,
  • Emilia Kozlowska and
  • Agnieszka Fiszer

Non-coding RNAs (ncRNAs) have been reported to be implicated in cell fate determination and various human diseases. All ncRNA molecules are emerging as key regulators of diverse cellular processes; however, little is known about the regulatory intera...

(This article belongs to the Special Issue RNA Regulatory Networks at the Crossroad of Human Diseases 2.0)
  • Review
  • Open Access
200 Views
25 Pages

29 October 2026

Spatial organization in the nucleus is an active layer of RNA regulation in skeletal muscle, yet localization is often interpreted more strongly than the evidence permits. This critical review compares physiological nuclear RNA compartments with path...

(This article belongs to the Special Issue MicroRNAs and Other Non-Coding RNAs in Regulation, Biomarker Discovery, and Therapeutic Targeting)
  • Article
  • Open Access
306 Views
30 Pages

From Prior to Frequency: A Progressive Structure Recovery Network for Remote Sensing Road Segmentation

  • Yulin Cao,
  • Haoyu Sha,
  • Xiaocong Wu,
  • Qiaolin Ye and ,
  • Wen Lu and
  • Le Sun
  • + 1 author+ 0 author

2 October 2026

Roads in remote sensing imagery often contain narrow branches, complex boundaries, and long-range connections. Background interference and repeated downsampling make these structures difficult to preserve. To address these challenges, we propose a Pr...

(This article belongs to the Section Remote Sensing Image Processing)
  • Article
  • Open Access
9 Citations
3,691 Views
20 Pages

Studying the Effect of MBNL1 and MBNL2 Loss in Skeletal Muscle Regeneration

  • Ramesh S. Yadava,
  • Mahua Mandal and
  • Mani S. Mahadevan

26 February 2024

Loss of function of members of the muscleblind-like (MBNL) family of RNA binding proteins has been shown to play a key role in the spliceopathy of RNA toxicity in myotonic dystrophy type 1 (DM1), the most common muscular dystrophy affecting adults an...

(This article belongs to the Special Issue New Insights into the Use of Mouse Models for the Study of Musculoskeletal Diseases)